El Bezawy, Rihan <br/><br/>
Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism.  [electronic resource] 

 -  Journal of hematology & oncology  01 2017 
 - 19 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1756-8722 
<br/><br/><label>Standard No.: </label>10.1186/s13045-016-0387-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Proliferation<br/>Down-Regulation<br/>Heterografts<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>MAP Kinase Signaling System<br/>Mesothelioma--drug therapy<br/>Mesothelioma, Malignant<br/>Mice<br/>MicroRNAs--genetics<br/>Peritoneal Neoplasms--pathology<br/>Proto-Oncogene Proteins--antagonists & inhibitors<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Proto-Oncogene Proteins c-met--antagonists & inhibitors<br/>Receptor Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Signal Transduction<br/>Axl Receptor Tyrosine Kinase